The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 5,207 | 524,929 | SH | SOLE | 0 | 524,929 | 0 | 0 | |
APOLLO ENDOSURGERY INC | COM | 03767D108 | 747 | 119,200 | SH | SOLE | 0 | 119,200 | 0 | 0 | |
APPLE INC | COM | 037833100 | 2 | 14 | SH | SOLE | 0 | 14 | 0 | 0 | |
BIO-PATH HOLDINGS INC | COM | 09057N201 | 766 | 383,088 | SH | SOLE | 0 | 383,088 | 0 | 0 | |
LEXICON PHARMACEUTICALS INC | COM | 528872302 | 306 | 35,714 | SH | SOLE | 0 | 35,714 | 0 | 0 | |
PLX PHARMA INC | COM | 72942A107 | 210 | 62,673 | SH | SOLE | 0 | 62,673 | 0 | 0 | |
PORTLAND GENERAL ELECTRIC CO | COM | 736508847 | 5 | 118 | SH | SOLE | 0 | 118 | 0 | 0 | |
SPDR S&P 500 ETF TRUST | ETFS | 78462F103 | 229,637 | 872,645 | SH | SOLE | 0 | 872,645 | 0 | 0 | |
TEXAS INSTRUMENTS INC | COM | 882508104 | 3,324 | 32,000 | SH | SOLE | 0 | 32,000 | 0 | 0 | |
VANGUARD 500 INDEX FUND | ETFS | 922908363 | 2,923 | 12,076 | SH | SOLE | 0 | 12,076 | 0 | 0 | |
VANGUARD ENERGY ETF | ETFS | 92204A306 | 1,057 | 11,445 | SH | SOLE | 0 | 11,445 | 0 | 0 | |
VANGUARD FTSE DEV MKTS | ETFS | 921943858 | 3,243 | 73,284 | SH | SOLE | 0 | 73,284 | 0 | 0 | |
VANGUARD MID-CAP VALUE ETF | ETFS | 922908512 | 2,883 | 26,356 | SH | SOLE | 0 | 26,356 | 0 | 0 | |
VANGUARD MSCI EMERGING MKTS | ETFS | 922042858 | 2,649 | 56,389 | SH | SOLE | 0 | 56,389 | 0 | 0 | |
VANGUARD REIT ETF | ETFS | 922908553 | 738 | 9,784 | SH | SOLE | 0 | 9,784 | 0 | 0 |